KOMEN GREATER DETROIT AFFILIATE ANNOUNCEMENT
Dear Komen supporter,
Exciting changes have been taking place that will position us to successfully fulfill our mission in 2018 and beyond! We are proud to officially announce the formation of the Susan G. Komen® Greater Detroit Affiliate.
The Komen Detroit Race for the Cure (RFTC) was established in 1992 in partnership with the Michigan Cancer Foundation, now the Barbara Ann Karmanos Cancer Institute. This 25-year partnership has been highly successful and has raised more than $29 million to invest in the fight against breast cancer. By working in collaboration with our valued partners at Karmanos, the decision was made to transition the current Race arrangement to a fully functioning Affiliate of Susan G. Komen. The goal of this evolution is to establish a strong, sustainable Affiliate capable of reaching larger amounts of women and men in the Metro Detroit area while continuing to honor the traditions, culture and accomplishments of our respected previous partnership with Karmanos.
Preparation for this transition began two years ago with the recruitment of a Founding Board of Directors. The Founding Board, comprised of nine enthusiastic and dedicated individuals, have been working tirelessly to develop the operational framework of the Affiliate. This work took place while our devoted RTFC staff and army of volunteers continued to successfully manage and execute Races in both 2016 and 2017. In 2018, with the establishment of our new Affiliate, we will be able to open new revenue and mission opportunities. While the Detroit Race for the Cure will continue to be an important yearly event, we will be in a position to better leverage national programs and raise funds from local supporters outside of the race environment.
To help us navigate these exciting changes, the Board has recruited and hired a new Executive Director, Aimee Nimeh. Aimee comes to us from Common Ground where she held the position of Vice President of Programs and Services. With a Masters Degree in Social Work and over 13 years of experience in the non-profit environment, Aimee’s leadership will be vital in responding to the changing non-profit landscape, to fully capitalize on organizational efficiencies and national programs, and to maximize our impact on the communities we serve.
Thank you for your continued support and commitment to our organization. We are confident that if we continue to work together we will reach Komen’s Bold Goal of cutting breast cancer mortality by 50% by 2026.
Board of Directors